LINCS MCF 10A Common Project: Fixed-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Repeat performed by Scientist B in 2019 to assess reproducibility. Dataset 1 of 2: Normalized growth rate inhibition values. - Dataset (ID:20359)

Filter results: >>>>
Small Molecule barcode cell_count frac_dead corpse_count cell_count_dead row column agent concentration role timepoint replicate cell_line dead_count fraction_dead cell_count__time0 dead_count__time0 cell_count__ctrl dead_count__ctrl fraction_dead__ctrl increase_fraction_dead GRvalue
Dasatinib
180622_BG_6
4577 0.1002 132 340 3 22
Dasatinib
0.997999808
treatment
72 2
MCF10A-GM_1
472 0.0935 832.0 168.3 20016 537.9 0.0261 0.06736 0.4500
Trametinib
180703_BG_11
3257 0.0486 115 49 6 22
Trametinib
0.319359801
treatment
72 3
MCF10A-GM_4
164 0.0479 1387.8 74.9 21564 711.9 0.0318 0.01614 0.2405
Vorinostat
180614_BG_04
16773 0.0196 91 239 5 22
Vorinostat
0.00998
treatment
72 1
MCF10A-GM_8
330 0.0193 889.0 105.5 17054 348.0 0.0200 -0.00070 0.9922
Palbociclib
180614_BG_02
15116 0.0159 23 218 14 22
Palbociclib
0.00998
treatment
72 1
MCF10A-GM_3
241 0.0157 889.0 105.5 17054 348.0 0.0200 -0.00430 0.9442
Etoposide
180703_BG_12
15802 0.0229 81 283 3 22
Etoposide
0.099799999
treatment
72 3
MCF10A-GM_7
364 0.0225 1387.8 74.9 21564 711.9 0.0318 -0.00928 0.8489
Taxol
180703_BG_11
762 0.8628 295 617 10 22
Paclitaxel
0.099799981
treatment
72 3
MCF10A-GM_4
912 0.5448 1387.8 74.9 21564 711.9 0.0318 0.51300 -0.1406